Sinovac Biotech Ltd (SVA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

NO. 15 ZHI TONG ROAD, BEIJING, CHINA 102200

Sinovac Biotech is a China-based biopharmaceutical holding company. Through its subsidiaries, Co. is engaged in the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Co.'s portfolio of regulatory-approved products consists of vaccines against the hepatitis A, hepatitis B and influenza viruses. Co.'s vaccines include Healive, Bilive which is a combined hepatitis A and B vaccine, Anflu which is a flu vaccine, Pandemic Influenza Vaccine, Japanese Encephalitis Vaccine and SARS Vaccine.

Data based on most recent fiscal year report
Market Cap466.994 Million Shares Outstanding57.02 Million Avg Volume201.779 Thousand
1-Yr BETA vs S&P TR Current Ratio2.03 Quick Ratio1.81
View SEC Filings from SVA instead.
Q4 2018 All Institutions Hedge Funds 1
To trade SVA now:
Filers who had this stock in their top 10: 2 1 (0.1%)
13F Filers holding this stock: 26 5 (0.5%)
Aggregate 13F shares on 12/31/2018: 12.054 Million 11.261 Million
Aggregate 13F shares on 09/30/2018: 12.261 Million 11.328 Million
Percent change: -1.68% -0.59%
Funds creating new positions: 3
Funds Adding to an existing position: 6 1
Funds closing out their position: 3
Funds reducing their position: 6 2
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding SVA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments